검색결과 : 15건
| No. | Article |
|---|---|
| 1 |
High-Level Recombinant Protein Production in CHO Cells Using Lentiviral Vectors and the Cumate Gene-Switch Gaillet B, Gilbert R, Broussau S, Pilotte A, Malenfant F, Mullick A, Garnier A, Massie B Biotechnology and Bioengineering, 106(2), 203, 2010 |
| 2 |
Production and characterization of the recombinant Islet Neogenesis Associated Protein (rINGAP) Assouline-Thomas B, Pilotte A, Petropavlovskaia M, Makhlin J, Ding JP, McLeod D, Hanley S, Massie B, Rosenberg L Protein Expression and Purification, 69(1), 1, 2010 |
| 3 |
Escherichia coli expression and refolding of E/K-coil-tagged EGF generates fully bioactive EGF for diverse applications Le PU, Lenferink AEG, Pinard M, Baardsnes J, Massie B, O'Connor-McCourt MD Protein Expression and Purification, 64(2), 108, 2009 |
| 4 |
High-level recombinant protein production in CHO cells using an adenoviral vector and the cumate gene-switch Gaillet B, Gilbert R, Amziani R, Guilbault C, Gadoury C, Caron AW, Mullick A, Garnier A, Massie B Biotechnology Progress, 23(1), 200, 2007 |
| 5 |
The short MCK1350 promoter/enhancer allows for sufficient dystrophin expression in skeletal muscles of mdx mice Larochelle N, Oualikene W, Dunant P, Massie B, Karpati G, Nalbantoglu J, Lochmuller H Biochemical and Biophysical Research Communications, 292(3), 626, 2002 |
| 6 |
Understanding factors that limit the productivity of suspension-based perfusion cultures operated at high medium renewal rates Mercille S, Johnson M, Lanthier S, Kamen AA, Massie B Biotechnology and Bioengineering, 67(4), 435, 2000 |
| 7 |
Dose-dependent reduction of apoptosis in nutrient-limited cultures of NS/0 myeloma cells transfected with the E1B-19K adenoviral gene Mercille S, Jolicoeur P, Gervais C, Paquette D, Mosser DD, Massie B Biotechnology and Bioengineering, 63(5), 516, 1999 |
| 8 |
Apoptosis-resistant E1B-19K-expressing NS/0 myeloma cells exhibit increased viability and chimeric antibody productivity under perfusion culture conditions Mercille S, Massie B Biotechnology and Bioengineering, 63(5), 529, 1999 |
| 9 |
Serum-free production of recombinant proteins and adenoviral vectors by 293SF-3F6 cells Cote J, Garnier A, Massie B, Kamen A Biotechnology and Bioengineering, 59(5), 567, 1998 |
| 10 |
Improvement of Recombinant Protein-Production with the Human Adenovirus/293S Expression System Using Fed-Batch Strategies Nadeau I, Garnier A, Cote J, Massie B, Chavarie C, Kamen A Biotechnology and Bioengineering, 51(6), 613, 1996 |